GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

FDA approval for restore3d’s all-metal PSI to boost ankle replacement market growth, says GlobalData

restore3d recently received FDA approval for the first all-metal patient specific instrument (PSI) in ankle arthroplasty. This product, named Axiom PSR, will be added to Kinos Medical’s total ankle system, which hosts a portfolio of ankle implants. The development may contribute to the continued growth of the ankle replacement market, which was estimated to be […]
Read more

Centerview Partners and Houlihan Lokey top M&A financial advisers in North America in Q1 2023, finds GlobalData

Centerview Partners and Houlihan Lokey were the top mergers and acquisitions (M&A) financial advisers in North America for Q1 2023 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, which ranks financial advisers by the value and volume of M&A deals on which they advised. Based on its Financial […]
Read more

China meat substitutes market at inflection point, gearing up to surge by 12.6% CAGR over 2022–27, says GlobalData

China’s meat substitutes market has reached an inflection point, spurred by the entry of domestic and multinational companies, a surge in product innovations, and favorable government policies. Moreover, health and lifestyle factors are encouraging more Millennials and Gen Z consumers to explore alternative proteins. As a result, value sales of meat substitutes in China will […]
Read more

Luminar to challenge leading companies in North American sensor industry with new Mexico facility, says GlobalData

Following the news that Luminar Technologies’ new automated, high-volume factory in Mexico started producing sensors; Rupayan Chakraborty, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “As a provider of cutting-edge sensor technology, Luminar Technologies is constantly designing and developing solutions for advanced driver assistance systems (ADAS). Their ultra-sensitive pixel-based sensors […]
Read more

Need for improved Alzheimer’s diagnosis and management highlighted at AD/PD 2023, says GlobalData

With the advent of novel disease-modifying therapies (DMTs), the future of Alzheimer’s disease (AD) diagnosis and management has been a key theme at the AD/PD 2023 International Conference on AD and Parkinson’s disease (PD), says GlobalData, a leading data and analytics company. Pippa Salter, Senior Neurology Analyst at GlobalData, comments: “Following the FDA approvals of Biogen’s […]
Read more
1 117 118 119 120 121 136